A detailed history of Balanced Rock Investment Advisor transactions in Amgen Inc stock. As of the latest transaction made, Balanced Rock Investment Advisor holds 1,515 shares of AMGN stock, worth $478,740. This represents 0.4% of its overall portfolio holdings.

Number of Shares
1,515
Previous 1,563 3.07%
Holding current value
$478,740
Previous $444 Million 6.52%
% of portfolio
0.4%
Previous 0.38%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$262.75 - $319.31 $12,612 - $15,326
-48 Reduced 3.07%
1,515 $473 Million
Q1 2024

May 13, 2024

SELL
$268.87 - $324.56 $91,146 - $110,025
-339 Reduced 17.82%
1,563 $444 Million
Q4 2023

Feb 13, 2024

BUY
$255.7 - $288.46 $486,341 - $548,650
1,902 New
1,902 $548 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Balanced Rock Investment Advisor Portfolio

Follow Balanced Rock Investment Advisor and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balanced Rock Investment Advisor, based on Form 13F filings with the SEC.

News

Stay updated on Balanced Rock Investment Advisor with notifications on news.